No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Blast Crisis / drug therapy
-
Blast Crisis / genetics*
-
Blast Crisis / pathology
-
Fatal Outcome
-
Humans
-
Hydroxyurea / therapeutic use
-
Immunologic Factors / therapeutic use
-
Interferon alpha-2
-
Interferon-alpha / therapeutic use
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
-
Male
-
Middle Aged
-
Philadelphia Chromosome*
-
Recombinant Proteins
-
Remission Induction
Substances
-
Immunologic Factors
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Hydroxyurea